Collaborative Studies with Cipla Pharmaceuticals on Screening of Generic Drugs for Par-4 Secretion

Grants and Contracts Details

StatusFinished
Effective start/end date2/9/15 → 10/1/15

Funding

  • Cipla Limited: $35,350.00